Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03606733Not ApplicableUnknown

Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal Disorders

Role: lead

NCT03226951Not ApplicableCompleted

SDM Laser for Non Central Diabetic CSME

Role: lead

NCT02772497Phase 2Completed

3 Month Outcome of Ziv-aflibercept for DME

Role: lead

NCT02705274Phase 2Completed

PRP vs Bevacizumab for PDR Treatment

Role: lead

All 4 trials loaded